APA (7th ed.) Citation

Curtin, F., Bernard, C., Levet, S., Perron, H., Porchet, H., Médina, J., . . . Simpson, R. (2018). A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti‐HERV‐W‐Env monoclonal antibody. Diabetes, obesity & metabolism, 20(9), 2075-2084. https://doi.org/10.1111/dom.13357

Chicago Style (17th ed.) Citation

Curtin, Francois, Corinne Bernard, Sandrine Levet, Hervé Perron, Hervé Porchet, Julie Médina, Sam Malpass, David Lloyd, and Richard Simpson. "A New Therapeutic Approach for Type 1 Diabetes: Rationale for GNbAC1, an Anti‐HERV‐W‐Env Monoclonal Antibody." Diabetes, Obesity & Metabolism 20, no. 9 (2018): 2075-2084. https://doi.org/10.1111/dom.13357.

MLA (9th ed.) Citation

Curtin, Francois, et al. "A New Therapeutic Approach for Type 1 Diabetes: Rationale for GNbAC1, an Anti‐HERV‐W‐Env Monoclonal Antibody." Diabetes, Obesity & Metabolism, vol. 20, no. 9, 2018, pp. 2075-2084, https://doi.org/10.1111/dom.13357.